Glofitamab. Anti-CD20 T-cell-engaging bispecific antibody, Treatment of non-Hodgkin lymphoma
-
Published:2022
Issue:10
Volume:47
Page:715
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Gaskill E.,Price S.
Subject
Pharmacology (medical),Pharmacology